LYEL
Lyell Immunopharma, Inc.
Company overview
- Market capitalization
- $238.68M
- Employees
- 161
- Latest publication
- 2026-09-29
About Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company's lead product candidate include rondecabtagene autoleucel, an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development, which is in pivotal PiNACLE trial in the 3L+ setting and in a Phase 1/2 clinical trial in the 2L setting, as well as a second pivotal trial, PiNACLE-H2H, which is a Phase 3 head-to-head CAR T cell therapy randomized controlled trial of ronde-cel for LBCL in the 2L setting for the treatment of large B-cell lymphoma; and LYL273, a GCC-targeted CAR T-cell product candidate enhanced with CD19 CAR expression and controlled cytokine release designed to improve CAR T-cell expansion, immune cell infiltration, and cancer cell killing in the hostile solid tumor microenvironment, which is in Phase 1 clinical trial for the treatment of refractory metastatic colorectal cancer. The company develops therapies using various approaches, such as c-Jun overexpression and NR4A3 gene knockout, to endow functional resistance to exhaustion; Epi-R to generate population of stem-like T cells with reduced exhaustion and improved proliferation and antitumor activity; and CD62L positive enrichment to generate CAR T cells with enhanced antitumor activity. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,000USD | 6,000USD | 15,000USD | 8,000USD | 7,000USD | 11,000USD | 34,000USD | 13,000USD |
| Cost Of Revenue | 2,332,000USD | 2,397,000USD | — | 3,135,000USD | — | 5,026,000USD | — | 4,901,000USD |
| Gross Profit | -2,330,000USD | 6,000USD | 15,000USD | 8,000USD | 7,000USD | 11,000USD | 34,000USD | 13,000USD |
| Research Development | 36,604,000USD | 52,199,000USD | 28,172,000USD | 34,857,000USD | 43,447,000USD | 48,668,000USD | 39,500,000USD | 40,261,000USD |
| Selling General Administrative | 9,555,000USD | 10,616,000USD | 10,687,000USD | 9,786,000USD | 14,046,000USD | 14,522,000USD | 11,769,000USD | 12,256,000USD |
| Unclassified Operating Expenses | -2,332,000USD | -1,497,000USD | -1,591,000USD | 2,505,000USD | — | 137,968,000USD | — | — |
| Total Operating Expenses | 43,827,000USD | 61,318,000USD | 37,268,000USD | 47,148,000USD | 57,374,000USD | 201,158,000USD | 50,539,000USD | 51,541,000USD |
| Operating Income | -46,157,000USD | -61,312,000USD | -37,253,000USD | -47,140,000USD | -57,367,000USD | -201,147,000USD | -50,505,000USD | -51,528,000USD |
| Interest Income | 2,194,000USD | 2,676,000USD | 3,266,000USD | 3,276,000USD | 3,862,000USD | 4,920,000USD | 5,965,000USD | 6,364,000USD |
| Net Interest Income | 2,194,000USD | 2,676,000USD | 3,266,000USD | 3,276,000USD | 3,862,000USD | 4,920,000USD | 5,965,000USD | 6,364,000USD |
| Income Before Tax | -24,153,000USD | -140,723,000USD | -38,846,000USD | -42,684,000USD | -52,195,000USD | -191,935,000USD | -44,583,000USD | -45,809,000USD |
| Net Income | -24,153,000USD | -140,723,000USD | -38,846,000USD | -42,684,000USD | -52,195,000USD | -191,935,000USD | -44,583,000USD | -45,809,000USD |
| Net Income From Continuing Ops | -24,153,000USD | -140,723,000USD | -38,846,000USD | -42,684,000USD | -52,195,000USD | -191,935,000USD | -44,583,000USD | -45,809,000USD |
| Ebit | -46,157,000USD | -61,312,000USD | -38,846,000USD | -45,697,000USD | -57,367,000USD | -62,666,000USD | -50,505,000USD | -51,528,000USD |
| Ebitda | -43,825,000USD | -58,915,000USD | -36,280,000USD | -42,562,000USD | -53,926,000USD | -57,640,000USD | -45,825,000USD | -46,627,000USD |
| Depreciation And Amortization | 2,332,000USD | 2,397,000USD | 2,566,000USD | 3,135,000USD | 3,441,000USD | 5,026,000USD | 4,680,000USD | 4,901,000USD |
| Reconciled Depreciation | 2,332,000USD | 2,397,000USD | 2,566,000USD | 3,135,000USD | 3,441,000USD | 5,026,000USD | 4,680,000USD | 4,901,000USD |
| Total Other Income Expense Net | 22,004,000USD | -79,411,000USD | -1,593,000USD | 4,456,000USD | 5,172,000USD | 9,212,000USD | 5,922,000USD | 5,719,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 36,000USD | 61,000USD | 130,000USD | 84,683,000USD | 10,650,000USD | 7,756,000USD | 657,000USD |
| Cost Of Revenue | 11,539,000USD | — | 20,250,000USD | 16,467,000USD | 14,535,000USD | 7,475,000USD | — |
| Gross Profit | -11,503,000USD | 61,000USD | 130,000USD | 84,683,000USD | 10,650,000USD | 7,756,000USD | 657,000USD |
| Research Development | 158,675,000USD | 171,603,000USD | 182,945,000USD | 159,188,000USD | 138,693,000USD | 182,243,000USD | 63,595,000USD |
| Selling General Administrative | 45,135,000USD | 52,041,000USD | 66,983,000USD | 117,307,000USD | 89,057,000USD | 46,881,000USD | 39,151,000USD |
| Unclassified Operating Expenses | -11,539,000USD | 135,172,000USD | -2,790,000USD | -4,754,000USD | -2,324,000USD | -9,431,000USD | — |
| Total Operating Expenses | 192,271,000USD | 358,816,000USD | 247,138,000USD | 271,741,000USD | 225,426,000USD | 219,693,000USD | 102,746,000USD |
| Operating Income | -203,774,000USD | -358,755,000USD | -247,008,000USD | -187,058,000USD | -214,776,000USD | -211,937,000USD | -102,089,000USD |
| Interest Income | 13,080,000USD | 24,068,000USD | 23,453,000USD | 7,053,000USD | 1,165,000USD | 5,939,000USD | 8,121,000USD |
| Net Interest Income | 13,080,000USD | 24,068,000USD | 23,453,000USD | 7,053,000USD | 1,165,000USD | 5,939,000USD | 8,121,000USD |
| Income Before Tax | -274,448,000USD | -342,994,000USD | -234,632,000USD | -183,118,000USD | -250,219,000USD | -204,472,000USD | -129,377,000USD |
| Net Income | -274,448,000USD | -342,994,000USD | -234,632,000USD | -183,118,000USD | -250,219,000USD | -204,472,000USD | -129,377,000USD |
| Net Income From Continuing Ops | -274,448,000USD | -342,994,000USD | -234,632,000USD | -183,118,000USD | -250,219,000USD | -204,472,000USD | -129,377,000USD |
| Ebit | -203,774,000USD | -220,274,000USD | -247,008,000USD | -187,058,000USD | -214,776,000USD | -219,721,000USD | -102,089,000USD |
| Ebitda | -192,235,000USD | -200,643,000USD | -226,758,000USD | -169,038,000USD | -201,152,000USD | -215,427,000USD | -100,833,000USD |
| Depreciation And Amortization | 11,539,000USD | 19,631,000USD | 20,250,000USD | 18,020,000USD | 13,624,000USD | 4,294,000USD | 1,256,000USD |
| Reconciled Depreciation | 11,539,000USD | 19,631,000USD | 20,250,000USD | 18,020,000USD | 13,624,000USD | 4,294,000USD | 1,256,000USD |
| Total Other Income Expense Net | -70,674,000USD | 15,761,000USD | 12,376,000USD | 3,940,000USD | -35,443,000USD | 7,465,000USD | -27,288,000USD |
| Income Tax Expense | — | — | -10,530,000USD | -178,364,000USD | 35,282,000USD | -5,939,000USD | -8,121,000USD |
| Net Income Applicable To Common Shares | — | — | — | -183,118,000USD | -250,219,000USD | -208,054,000USD | -130,521,000USD |
| Interest Expense | — | — | — | — | 1,165,000USD | 5,939,000USD | 0USD |
| Non Operating Income Net Other | — | — | — | — | -36,608,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 350,626,000USD | 340,052,000USD | 407,965,000USD | 385,453,000USD | 429,798,000USD | 490,859,000USD | 619,215,000USD | 654,142,000USD |
| Other Current Assets | 13,281,000USD | 13,719,000USD | 8,577,000USD | 5,424,000USD | 8,001,000USD | 9,067,000USD | 9,498,000USD | 8,705,000USD |
| Total Liab | 76,961,000USD | 91,850,000USD | 78,844,000USD | 86,530,000USD | 93,277,000USD | 108,035,000USD | 88,518,000USD | 87,641,000USD |
| Total Stockholder Equity | 273,665,000USD | 248,202,000USD | 329,121,000USD | 298,923,000USD | 336,521,000USD | 382,824,000USD | 530,697,000USD | 566,501,000USD |
| Other Current Liab | 31,479,000USD | 46,519,000USD | 29,310,000USD | 25,014,000USD | 29,319,000USD | 40,448,000USD | 22,782,000USD | 19,782,000USD |
| Common Stock | 2,000USD | 2,000USD | 2,000USD | 1,000USD | 30,000USD | 29,000USD | 26,000USD | 26,000USD |
| Capital Stock | 2,000USD | 2,000USD | 2,000USD | 1,000USD | 30,000USD | 29,000USD | 26,000USD | 26,000USD |
| Retained Earnings | -1,643,707,000USD | -1,619,554,000USD | -1,478,831,000USD | -1,439,985,000USD | -1,397,301,000USD | -1,345,106,000USD | -1,153,171,000USD | -1,108,588,000USD |
| Cash | 90,770,000USD | 60,181,000USD | 123,575,000USD | 98,804,000USD | 120,328,000USD | 105,597,000USD | 100,299,000USD | 133,424,000USD |
| Cash And Short Term Investments | 254,023,000USD | 247,220,000USD | 319,624,000USD | 276,790,000USD | 301,177,000USD | 370,527,000USD | 440,547,000USD | 491,119,000USD |
| Total Current Assets | 267,304,000USD | 260,939,000USD | 328,201,000USD | 282,214,000USD | 309,178,000USD | 379,594,000USD | 450,045,000USD | 499,824,000USD |
| Total Current Liabilities | 36,947,000USD | 49,412,000USD | 31,878,000USD | 36,903,000USD | 41,285,000USD | 53,788,000USD | 33,512,000USD | 30,879,000USD |
| Net Debt | -51,283,000USD | -18,260,000USD | -79,290,000USD | -43,697,000USD | -63,239,000USD | -46,629,000USD | -41,724,000USD | -73,203,000USD |
| Short Long Term Debt Total | 39,487,000USD | 41,921,000USD | 44,285,000USD | 55,107,000USD | 57,089,000USD | 58,968,000USD | 58,575,000USD | 60,221,000USD |
| Long Term Investments | 25,954,000USD | 19,000,000USD | 19,000,000USD | 39,059,000USD | 47,949,000USD | 32,014,000USD | 39,112,000USD | 19,000,000USD |
| Short Term Investments | 163,253,000USD | 187,039,000USD | 196,049,000USD | 177,986,000USD | 180,849,000USD | 264,930,000USD | 340,248,000USD | 357,695,000USD |
| Accounts Payable | 5,468,000USD | 2,893,000USD | 2,568,000USD | 3,379,000USD | 3,728,000USD | 5,366,000USD | 3,596,000USD | 4,199,000USD |
| Property Plant Equipment Net | 50,548,000USD | 53,642,000USD | 56,634,000USD | 60,066,000USD | 67,765,000USD | 72,939,000USD | 124,709,000USD | 130,792,000USD |
| Property Plant Equipment Gross | 50,548,000USD | 127,920,000USD | 56,634,000USD | 60,066,000USD | 67,765,000USD | 143,618,000USD | 124,709,000USD | 130,792,000USD |
| Accumulated Other Comprehensive Income | -9,000USD | 242,000USD | 201,000USD | 57,000USD | 157,999USD | 291,000USD | 759,999USD | -397,000USD |
| Common Stock Shares Outstanding | 21,876,000shares | 17,093,000shares | 18,268,000shares | 14,793,000shares | 14,754,900shares | 13,326,950shares | 12,815,450shares | 12,769,900shares |
| Non Current Assets Total | 83,322,000USD | 79,113,000USD | 79,764,000USD | 103,239,000USD | 120,620,000USD | 111,265,000USD | 169,170,000USD | 154,318,000USD |
| Non Current Liabilities Total | 40,014,000USD | 42,438,000USD | 46,966,000USD | 49,627,000USD | 51,992,000USD | 54,247,000USD | 55,006,000USD | 56,762,000USD |
| Non Current Liabilities Other | 527,000USD | 517,000USD | 2,681,000USD | 3,030,000USD | 3,141,000USD | 3,253,000USD | 3,565,000USD | 3,439,000USD |
| Non Currrent Assets Other | 13,774,000USD | 6,471,000USD | 4,130,000USD | 4,114,000USD | 4,906,000USD | 6,312,000USD | 5,349,000USD | 4,526,000USD |
| Net Working Capital | 230,357,000USD | 211,527,000USD | 296,323,000USD | 245,311,000USD | 267,893,000USD | 325,806,000USD | 416,533,000USD | 468,945,000USD |
| Unclassified Non Current Assets | -6,954,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 39,487,000USD | 41,921,000USD | 44,285,000USD | 46,597,000USD | 48,851,000USD | 50,994,000USD | 51,441,000USD | 53,323,000USD |
| Unclassified Equity | 1,917,377,000USD | 1,867,510,000USD | 1,807,747,000USD | 1,738,849,000USD | 1,733,604,001USD | 1,727,581,000USD | 1,683,056,001USD | 1,675,434,000USD |
| Short Term Debt | — | — | — | 8,510,000USD | 8,238,000USD | 7,974,000USD | 7,134,000USD | 6,898,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 340,052,000USD | 490,859,000USD | 750,029,000USD | 937,561,000USD | 1,127,406,000USD | 908,280,000USD | 555,631,000USD |
| Other Current Assets | 13,719,000USD | 9,067,000USD | 8,463,000USD | 11,143,000USD | 11,492,000USD | 4,928,000USD | 4,210,000USD |
| Total Liab | 91,850,000USD | 108,035,000USD | 95,077,000USD | 104,309,000USD | 197,619,000USD | 189,840,000USD | 147,576,000USD |
| Total Stockholder Equity | 248,202,000USD | 382,824,000USD | 654,952,000USD | 833,252,000USD | 929,787,000USD | 718,440,000USD | 408,055,000USD |
| Other Current Liab | 46,519,000USD | 40,448,000USD | 23,429,000USD | 28,577,000USD | 37,374,000USD | 30,177,000USD | 14,346,000USD |
| Common Stock | 2,000USD | 29,000USD | 25,000USD | 25,000USD | 24,000USD | 2,000USD | 1,000USD |
| Capital Stock | 2,000USD | 29,000USD | 25,000USD | 25,000USD | 24,000USD | 1,010,970,000USD | 519,164,000USD |
| Retained Earnings | -1,619,554,000USD | -1,345,106,000USD | -1,002,112,000USD | -767,480,000USD | -584,362,000USD | -334,143,000USD | -129,671,000USD |
| Cash | 60,181,000USD | 105,597,000USD | 145,647,000USD | 123,554,000USD | 293,828,000USD | 140,406,000USD | 96,674,000USD |
| Cash And Short Term Investments | 247,220,000USD | 370,527,000USD | 546,223,000USD | 640,152,000USD | 614,794,000USD | 612,619,000USD | 436,049,000USD |
| Total Current Assets | 260,939,000USD | 379,594,000USD | 554,686,000USD | 651,295,000USD | 626,286,000USD | 617,547,000USD | 440,259,000USD |
| Total Current Liabilities | 49,412,000USD | 53,788,000USD | 34,519,000USD | 37,028,000USD | 46,738,000USD | 49,285,000USD | 22,045,000USD |
| Net Debt | -18,260,000USD | -46,629,000USD | -82,480,000USD | -55,852,000USD | -226,009,000USD | -85,832,000USD | -69,205,000USD |
| Short Long Term Debt Total | 41,921,000USD | 58,968,000USD | 63,167,000USD | 67,702,000USD | 67,819,000USD | 54,574,000USD | 27,469,000USD |
| Long Term Investments | 19,000,000USD | 32,014,000USD | 48,507,000USD | 115,041,000USD | 330,532,000USD | 163,443,000USD | 68,983,000USD |
| Short Term Investments | 187,039,000USD | 264,930,000USD | 400,576,000USD | 516,598,000USD | 320,966,000USD | 472,213,000USD | 339,375,000USD |
| Accounts Payable | 2,893,000USD | 5,366,000USD | 4,817,000USD | 3,917,000USD | 3,207,000USD | 9,396,000USD | 2,844,000USD |
| Property Plant Equipment Net | 53,642,000USD | 72,939,000USD | 142,317,000USD | 166,265,000USD | 166,639,000USD | 124,055,000USD | 43,705,000USD |
| Property Plant Equipment Gross | 127,920,000USD | 143,618,000USD | 193,964,000USD | 198,649,000USD | 181,152,000USD | 124,055,000USD | 43,705,000USD |
| Accumulated Other Comprehensive Income | 242,000USD | 291,000USD | -94,000USD | -7,599,000USD | -1,623,000USD | 256,000USD | 454,000USD |
| Common Stock Shares Outstanding | 17,093,000shares | 13,074,000shares | 12,549,150shares | 12,354,000shares | 12,136,900shares | 12,329,000shares | 12,329,000shares |
| Non Current Assets Total | 79,113,000USD | 111,265,000USD | 195,343,000USD | 286,266,000USD | 501,120,000USD | 290,733,000USD | 115,372,000USD |
| Non Current Liabilities Total | 42,438,000USD | 54,247,000USD | 60,558,000USD | 67,281,000USD | 150,881,000USD | 140,555,000USD | 125,531,000USD |
| Non Current Liabilities Other | 517,000USD | 3,253,000USD | 3,664,000USD | 4,113,000USD | 150,881,000USD | 532,000USD | — |
| Non Currrent Assets Other | 6,471,000USD | 6,312,000USD | 4,519,000USD | 4,960,000USD | 3,949,000USD | 3,235,000USD | 2,684,000USD |
| Net Working Capital | 211,527,000USD | 325,806,000USD | 520,167,000USD | 614,267,000USD | 579,548,000USD | 568,262,000USD | 418,214,000USD |
| Unclassified Non Current Liabilities | 41,921,000USD | 50,994,000USD | 56,894,000USD | 59,055,000USD | -84,231,000USD | 50,425,000USD | 27,125,000USD |
| Unclassified Equity | 1,867,510,000USD | 1,727,581,000USD | 1,657,108,000USD | 1,608,281,000USD | 1,515,724,000USD | 41,355,000USD | 18,107,000USD |
| Short Term Debt | — | 7,974,000USD | 6,273,000USD | 4,534,000USD | 1,169,000USD | 3,617,000USD | 344,000USD |
| Current Deferred Revenue | — | — | 20,360,000USD | 21,869,000USD | 4,988,000USD | 6,095,000USD | 4,511,000USD |
| Unclassified Current Liabilities | — | — | -20,360,000USD | -21,869,000USD | — | — | — |
| Other Liab | — | — | — | 4,113,000USD | 84,231,000USD | 89,598,000USD | 98,406,000USD |
| Other Assets | — | — | — | 4,960,000USD | 3,949,000USD | 3,235,000USD | 2,684,000USD |
| Net Tangible Assets | — | — | — | 833,252,000USD | 929,787,000USD | -292,528,000USD | -111,108,000USD |
| Unclassified Non Current Assets | — | — | — | -4,960,000USD | — | -3,235,000USD | -2,684,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -24,153,000USD | -140,723,000USD | -38,846,000USD | -42,684,000USD | -52,195,000USD | -191,935,000USD | -44,583,000USD | -45,809,000USD |
| Depreciation | 2,332,000USD | 2,397,000USD | 2,566,000USD | 3,135,000USD | 3,441,000USD | 5,026,000USD | 4,680,000USD | 4,901,000USD |
| Stock Based Compensation | 4,295,000USD | 25,569,000USD | 5,232,000USD | 5,004,000USD | 6,024,000USD | 8,083,000USD | 7,622,000USD | 8,284,000USD |
| Other Non Cash Items | -15,605,000USD | 79,834,000USD | 2,607,000USD | 963,000USD | -2,454,000USD | 131,550,000USD | -3,798,000USD | -4,516,000USD |
| Change In Working Capital | -1,084,000USD | 672,000USD | -136,000USD | -876,000USD | -9,554,000USD | 34,000USD | 1,037,000USD | -954,000USD |
| Total Cash From Operating Activities | -38,510,000USD | -32,251,000USD | -28,577,000USD | -34,458,000USD | -54,738,000USD | -47,242,000USD | -35,042,000USD | -38,094,000USD |
| Capital Expenditures | -89,000USD | -304,000USD | -62,000USD | -168,000USD | -246,000USD | -44,000USD | -59,000USD | -331,000USD |
| Free Cash Flow | -38,599,000USD | -32,555,000USD | -28,639,000USD | -34,626,000USD | -54,984,000USD | -47,286,000USD | -35,101,000USD | -38,425,000USD |
| Investments | 17,467,000USD | 10,110,000USD | 3,349,000USD | 12,647,000USD | 69,466,000USD | 53,505,000USD | 1,918,000USD | 45,007,000USD |
| Total Cashflows From Investing Activities | 17,378,000USD | -31,365,000USD | 3,349,000USD | 12,647,000USD | 69,466,000USD | 53,505,000USD | 1,918,000USD | 45,007,000USD |
| Total Cash From Financing Activities | 51,722,000USD | 222,000USD | 50,000,000USD | 183,000USD | 1,000USD | 437,000USD | 0USD | 862,000USD |
| Issuance Of Capital Stock | 51,696,000USD | 0USD | — | — | 0USD | — | — | — |
| Change In Cash | 30,589,000USD | -63,394,000USD | 24,771,000USD | -21,628,000USD | 14,729,000USD | 5,298,000USD | -33,124,000USD | 7,774,000USD |
| Begin Period Cash Flow | 60,181,000USD | 125,160,000USD | 98,804,000USD | 122,016,000USD | 107,287,000USD | 100,299,000USD | 133,711,000USD | 125,650,000USD |
| End Period Cash Flow | 90,770,000USD | 61,766,000USD | 123,575,000USD | 100,388,000USD | 122,016,000USD | 105,597,000USD | 100,587,000USD | 133,424,000USD |
| Other Cashflows From Investing Activities | 17,561,000USD | -41,171,000USD | — | — | — | -31,346,000USD | — | 45,338,000USD |
| Other Cashflows From Financing Activities | 51,722,000USD | -1,000USD | — | -1,000USD | 1,000USD | 437,000USD | 103,000USD | 862,000USD |
| Unclassified Operating Cash Flow | -4,295,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -17,561,000USD | — | — | — | — | 31,390,000USD | — | -45,007,000USD |
| Unclassified Financing Cash Flow | -51,696,000USD | — | — | — | — | -36,011,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | 36,011,000USD | -734,000USD | 810,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -274,448,000USD | -342,994,000USD | -234,632,000USD | -183,118,000USD | -250,219,000USD | -204,472,000USD | -129,377,000USD |
| Depreciation | 11,539,000USD | 19,631,000USD | 20,250,000USD | 16,466,999USD | 13,624,000USD | 4,294,000USD | 1,256,000USD |
| Stock Based Compensation | 41,829,000USD | 33,144,000USD | 47,084,000USD | 81,924,000USD | 62,201,000USD | 33,261,000USD | 15,732,000USD |
| Other Non Cash Items | 80,950,000USD | 130,945,000USD | 183,000USD | 79,111,000USD | 4,624,000USD | 6,379,000USD | 42,573,000USD |
| Change In Working Capital | -9,894,000USD | -3,120,000USD | 3,421,000USD | -82,015,000USD | 4,015,000USD | -336,000USD | 110,808,000USD |
| Total Cash From Operating Activities | -150,024,000USD | -162,394,000USD | -163,694,000USD | -169,555,000USD | -126,249,000USD | -160,874,000USD | 39,474,000USD |
| Capital Expenditures | -780,000USD | -464,000USD | -2,686,000USD | -24,276,000USD | -65,504,000USD | -51,481,000USD | -16,047,000USD |
| Free Cash Flow | -150,804,000USD | -162,858,000USD | -166,380,000USD | -193,831,000USD | -191,753,000USD | -212,355,000USD | 23,427,000USD |
| Investments | 95,785,000USD | 122,424,000USD | 184,048,000USD | -11,540,000USD | -56,069,000USD | -222,035,000USD | -406,386,000USD |
| Total Cashflows From Investing Activities | 54,097,000USD | 122,424,000USD | 184,048,000USD | -11,540,000USD | -121,573,000USD | -273,516,000USD | -422,433,000USD |
| Total Cash From Financing Activities | 50,406,000USD | 1,326,000USD | 1,743,000USD | 10,635,000USD | 401,244,000USD | 476,790,000USD | 351,156,000USD |
| Issuance Of Capital Stock | 50,000,000USD | 0USD | 0USD | 0USD | 391,802,000USD | 492,467,000USD | 351,341,000USD |
| Change In Cash | -45,521,000USD | -38,644,000USD | 22,093,000USD | -170,274,000USD | 153,422,000USD | 42,400,000USD | -31,803,000USD |
| Begin Period Cash Flow | 107,287,000USD | 145,931,000USD | 123,554,000USD | 293,828,000USD | 140,872,000USD | 98,472,000USD | 130,275,000USD |
| End Period Cash Flow | 61,766,000USD | 107,287,000USD | 145,647,000USD | 123,554,000USD | 294,294,000USD | 140,872,000USD | 98,472,000USD |
| Other Cashflows From Investing Activities | -18,898,000USD | -31,346,000USD | 186,734,000USD | 12,736,000USD | -673,465,000USD | -864,909,000USD | -610,842,000USD |
| Other Cashflows From Financing Activities | -1,000USD | -76,000USD | -457,000USD | -461,000USD | 9,442,000USD | 488,596,000USD | 351,341,000USD |
| Unclassified Investing Cash Flow | -22,010,000USD | 31,810,000USD | -184,048,000USD | 11,540,000USD | 673,465,000USD | 864,909,000USD | 610,842,000USD |
| Sale Purchase Of Stock | — | 36,011,000USD | -457,000USD | -461,000USD | 401,244,000USD | -11,806,000USD | -185,000USD |
| Unclassified Financing Cash Flow | — | -34,609,000USD | 2,657,000USD | 11,557,000USD | -9,442,000USD | — | — |
| Change To Liabilities | — | — | — | -83,986,000USD | 8,308,000USD | -8,034,000USD | 104,626,000USD |
| Unclassified Operating Cash Flow | — | — | — | -81,923,999USD | 39,506,000USD | — | -1,518,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 153,422,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.